Subclinical myocardial injury lower in established celiac disease, CRP unaffected :- Medznat
EN | RU
EN | RU

Help Support

By clicking the "Submit" button, you accept the terms of the User Agreement, including those related to the processing of your personal data. More about data processing in the Policy.
Back

Gluten-free diet may confer cardioprotection in celiac disease, HUNT4 data suggest!

Celiac disease Celiac disease
Celiac disease Celiac disease

What's new?

Known—but not newly diagnosed—celiac disease associates with lower cardiac troponin I levels, suggesting a potential cardioprotective effect of a gluten-free diet, while no relationship is observed with C-reactive protein.

A large population-based analysis from the Trøndelag Health Study (HUNT4) challenges concerns about heightened cardiovascular disease (CVD) risk in celiac disease (CeD), showing that individuals with established CeD have lower levels of cardiac troponin I (cTnI), a biomarker of subclinical myocardial injury.

CeD is an immune-mediated ailment induced by gluten ingestion, marked by transglutaminase (TG2) antibodies, small intestinal villous atrophy, and malabsorption. Although chronic inflammation in CeD has been proposed as a contributor to CVD, prior evidence has been inconsistent. High-sensitivity cTnI reflects subtle myocardial injury and predicts future CVD risk, while C-reactive protein (CRP) serves as a marker of systemic inflammation.

In this cross-sectional study, researchers measured CRP and circulating cTnI concentrations in 37,559 subjects (mean age 55 years; 45% male) from HUNT4. Volunteers underwent serological screening for CeD using TG2 IgA and IgG antibodies. Seropositive individuals without a prior diagnosis were invited for confirmatory endoscopy with duodenal biopsies. Volunteers were categorized into 4 groups:

  • No CeD: 36,785 (97.94%)
  • Potential CeD: 170 (0.45%)
  • Known CeD (prior diagnosis): 268 (0.71%)
  • Newly diagnosed CeD: 336 (0.89%)

The relationships between CeD status, CRP, and cTnI were checked through linear regression models. Participants with newly diagnosed CeD had lower median CRP compared with those without CeD (1.0 mg/L vs 1.3 mg/L). However, after full multivariable adjustment, CeD status was not independently related to CRP, indicating no clear link between CeD and systemic inflammation.

Median cTnI concentrations were lower in both newly diagnosed (1.5 ng/L) and known CeD (1.5 ng/L) compared with no CeD (1.7 ng/L). In fully adjusted models, however, only known CeD remained independently associated with lower cTnI levels (β −0.154). Neither newly diagnosed nor potential CeD exhibited independent associations with cTnI after adjustment. These findings suggest:

  • Established (treated) CeD is associated with lower circulating cTnI.
  • Newly diagnosed CeD does not show the same independent association.
  • Systemic inflammation, as measured by CRP, does not appear elevated in CeD.

The selective association with known CeD raises the possibility that long-term adherence to a gluten-free diet may minimize subclinical myocardial injury, potentially lowering cardiovascular risk.

Source:

European Heart Journal

Article:

Celiac disease, systemic inflammation, and the risk of subclinical myocardial injury

Authors:

J Young et al.

Comments (0)

You want to delete this comment? Please mention comment Invalid Text Content Text Content cannot me more than 1000 Something Went Wrong Cancel Confirm Confirm Delete Hide Replies View Replies View Replies en
Try: